Iowa City-based University of Iowa Health Care and Mission Cancer + Blood plan to partner in a $280 million deal to create a comprehensive cancer care network.

The U.S. spent $99 billion on both oral and clinician-administered cancer therapies in 2023, according to a report published in April by analytics firm IQVIA. As cancer drug prices continue to increase, spending is projected to grow.

Daniel Nikcevich, MD, saw a boat heading straight for him during a fishing trip in rural Minnesota. 

Rochester, Minn.-based Mayo Clinic has broken ground on a $9 million cancer center expansion at its New Prague, Minn., medical campus.

Along with the premarket approval of Siemens' 3D breast-imaging technology, the FDA  approved seven oncology and hematology drugs in September. 

Six U.S. health systems and cancer centers have joined the recently launched Together for Supportive Cancer Care consortium alongside more than 30 research institutions and advocacy groups with the aim to make supportive cancer care the standard of care.

Michel Sadelain, MD, PhD, a CAR-T therapy innovator and one of the world's top immunologists, has left New York City-based Memorial Sloan Kettering Cancer Center for two new roles at Columbia University Irving Medical Center, also in New York City.

From 2012 to 2021, breast cancer incidence has risen 1%, with steep increases among young women and Asian American/Pacific Islander women, according to the American Cancer Society. 

Moffitt Cancer Center patients will soon have access to on-demand virtual care services. 

An AI-empowered blood test was able to more reliably identify ovarian cancer by detecting DNA fragments and protein biomarkers, according to a study published Sept. 30 in the American Association for Cancer Research's journal, Cancer Discovery.

The FDA's Oncologic Drugs Advisory Committee has voted to restrict the use of nivolumab and pembrolizumab immunotherapy drugs based on the programmed death-ligand 1 expression levels of patients, according to a Sept. 30 Medscape report. 

Increased demand for colonoscopies has prompted healthcare leaders to hone preventive screening, service delivery and innovation strategies in recent years.1

Boston-based Dana-Farber Cancer Institute will lead 12 other health systems and academic institutions across the U.S. in a new cancer consortium aimed at addressing health equity and survival rates among pediatric populations.

Rockledge, Fla.-based Health First will transfer ownership of its Health First Cancer Institute building to Titusville, Fla.-based Parrish Healthcare as part of the health systems' collaboration. 

Leaders from two top-five cancer centers, as ranked by U.S. News & World Report, shared with Becker's the changes they want to see in cancer care.

Houston-based University of Texas MD Anderson Cancer Center is publishing an open-access, peer-reviewed academic journal. Advances in Cancer Education & Quality Improvement will share research and insights with the aim of improving cancer care and patient outcomes. 

Here are hospitals and health systems opening and expanding cancer centers in 2024:

Chicago-based Northwestern Medicine has named Hidayatullah Munshi, MD, chief of the hematology and oncology division in the Department of Medicine at the Feinberg School of Medicine. 

Surgeons at Chicago-based Northwestern Medicine have performed a double-lung transplant for a patient with stage 4 colorectal cancer through its double-lung replacement and multidisciplinary care program, a first-of-its-kind initiative reserved for patients whose cancers do not respond to standard treatments. 

As part of a $260 million investment, Johnson City, Tenn.-based Ballad Health has entered a 10-year partnership with Siemens Healthineers affiliate Varian to advance oncology services in the health system.